Latest Breaking News On - Antlera therapeutics inc - Page 1 : comparemela.com

Researchers develop first drug using synthetic protein to treat incurable eye diseases

Researchers develop first drug using synthetic protein to treat incurable eye diseases
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Jarrett adamsSachdev sidhuUniversity of waterloo school pharmacyAntlera therapeutics incLevi blazer

Waterloo researchers developing first drug of its kind to treat incurable eye diseases

Researchers have developed a novel synthetic protein to treat macular degeneration and other incurable eye diseases that lead to blindness in millions of people. It is the first drug of its kind and is currently in human trials. Neovascular age-related macular degeneration (AMD) affects more than 200 million people worldwide. In addition, millions more with type-1 or type-2 diabetes are at risk of developing diabetic macular edema (DME). Both diseases currently have no cure. The novel an.

Sachdev sidhuJarrett adamsAntlera therapeutics incUniversity of waterloo school pharmacyLevi blazerPress release image

AntlerA antibody drug for treatment of vascular retinopathies

/PRNewswire/ AntlerA has applied its next generation programmable ANT platform to develop therapeutics for treating retinopathies. Blood vessels that supply.

Sachdev sidhuHarald jungeSekar seshagiriUniversity of torontoUniversity of minnesota medical schoolAntlera therapeutics incMinnesota medical schoolAntlera norrin mimeticStephane angersAntlera therapeuticsHealth care amp hospitalsMedical pharmaceuticalsClinical trials amp medical discoveriesசச்ச்தேவ் ஸிட்ஹுசேகர் சேஷகிரிபல்கலைக்கழகம் ஆஃப் டொராண்டோ